Serveur d'exploration sur la grippe en Allemagne

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[Community-acquired and nosocomial pneumonia].

Identifieur interne : 000544 ( Main/Exploration ); précédent : 000543; suivant : 000545

[Community-acquired and nosocomial pneumonia].

Auteurs : T. Welte [Allemagne]

Source :

RBID : pubmed:14567088

Descripteurs français

English descriptors

Abstract

Mortality of pneumonia is low in the outside setting (1%) but rises up to 20% in hospital admitted patients. Early diagnosis and standardized therapy improve patient's prognosis. For community acquired pneumonia age, comorbidity and the setting of therapy (outside department, normal ward or intensive care unit) are the most important variables to choose an adequate antibiotic treatment. For nosocomial pneumonia risk stratification is according to severity of illness, length of hospital stay and antibiotic pretreatment. In the outpatient setting a 7-day monotherapy is mostly successful. In severe illness the combination of a betalactam antibiotic with a new fluorchinolon seems to be superior to an aminoglycosid therapy. Antibiotic resistance due to mistakes in antibiotic therapy is an increasing problem in the intensive care unit. Therefore, pneumonia preventive measures like influenza and pneumococcal vaccination become more important. Standardized hygienical procedures help to reduce nosocomial, mainly ventilator associated pneumonia.

DOI: 10.1007/s00108-003-0964-y
PubMed: 14567088


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[Community-acquired and nosocomial pneumonia].</title>
<author>
<name sortKey="Welte, T" sort="Welte, T" uniqKey="Welte T" first="T" last="Welte">T. Welte</name>
<affiliation wicri:level="1">
<nlm:affiliation>Bereich Pneumologie und internistische Intensivmedizin, Otto-von-Guericke-Universität Magdeburg. tobias.welte@medizin.uni-magdeburg.de</nlm:affiliation>
<country wicri:rule="url">Allemagne</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:14567088</idno>
<idno type="pmid">14567088</idno>
<idno type="doi">10.1007/s00108-003-0964-y</idno>
<idno type="wicri:Area/Main/Corpus">000549</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000549</idno>
<idno type="wicri:Area/Main/Curation">000549</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000549</idno>
<idno type="wicri:Area/Main/Exploration">000549</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">[Community-acquired and nosocomial pneumonia].</title>
<author>
<name sortKey="Welte, T" sort="Welte, T" uniqKey="Welte T" first="T" last="Welte">T. Welte</name>
<affiliation wicri:level="1">
<nlm:affiliation>Bereich Pneumologie und internistische Intensivmedizin, Otto-von-Guericke-Universität Magdeburg. tobias.welte@medizin.uni-magdeburg.de</nlm:affiliation>
<country wicri:rule="url">Allemagne</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Der Internist</title>
<idno type="ISSN">0020-9554</idno>
<imprint>
<date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Anti-Bacterial Agents (adverse effects)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Community-Acquired Infections (diagnosis)</term>
<term>Community-Acquired Infections (drug therapy)</term>
<term>Community-Acquired Infections (economics)</term>
<term>Community-Acquired Infections (mortality)</term>
<term>Comorbidity (MeSH)</term>
<term>Cost of Illness (MeSH)</term>
<term>Cross Infection (diagnosis)</term>
<term>Cross Infection (drug therapy)</term>
<term>Cross Infection (economics)</term>
<term>Cross Infection (mortality)</term>
<term>Germany (MeSH)</term>
<term>Hospital Mortality (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Intensive Care Units (MeSH)</term>
<term>Pneumococcal Vaccines (administration & dosage)</term>
<term>Pneumonia, Bacterial (diagnosis)</term>
<term>Pneumonia, Bacterial (drug therapy)</term>
<term>Pneumonia, Bacterial (economics)</term>
<term>Pneumonia, Bacterial (mortality)</term>
<term>Pneumonia, Pneumococcal (diagnosis)</term>
<term>Pneumonia, Pneumococcal (drug therapy)</term>
<term>Pneumonia, Pneumococcal (economics)</term>
<term>Pneumonia, Pneumococcal (mortality)</term>
<term>Residence Characteristics (MeSH)</term>
<term>Risk Factors (MeSH)</term>
<term>Survival Rate (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Allemagne (MeSH)</term>
<term>Antibactériens (effets indésirables)</term>
<term>Antibactériens (usage thérapeutique)</term>
<term>Caractéristiques de l'habitat (MeSH)</term>
<term>Comorbidité (MeSH)</term>
<term>Coûts indirects de la maladie (MeSH)</term>
<term>Facteurs de risque (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infection croisée (diagnostic)</term>
<term>Infection croisée (mortalité)</term>
<term>Infection croisée (traitement médicamenteux)</term>
<term>Infection croisée (économie)</term>
<term>Infections communautaires (diagnostic)</term>
<term>Infections communautaires (mortalité)</term>
<term>Infections communautaires (traitement médicamenteux)</term>
<term>Infections communautaires (économie)</term>
<term>Mortalité hospitalière (MeSH)</term>
<term>Pneumonie à pneumocoques (diagnostic)</term>
<term>Pneumonie à pneumocoques (mortalité)</term>
<term>Pneumonie à pneumocoques (traitement médicamenteux)</term>
<term>Pneumonie à pneumocoques (économie)</term>
<term>Pneumopathie bactérienne (diagnostic)</term>
<term>Pneumopathie bactérienne (mortalité)</term>
<term>Pneumopathie bactérienne (traitement médicamenteux)</term>
<term>Pneumopathie bactérienne (économie)</term>
<term>Taux de survie (MeSH)</term>
<term>Unités de soins intensifs (MeSH)</term>
<term>Vaccins antipneumococciques (administration et posologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Pneumococcal Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Anti-Bacterial Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anti-Bacterial Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Vaccins antipneumococciques</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Community-Acquired Infections</term>
<term>Cross Infection</term>
<term>Pneumonia, Bacterial</term>
<term>Pneumonia, Pneumococcal</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Infection croisée</term>
<term>Infections communautaires</term>
<term>Pneumonie à pneumocoques</term>
<term>Pneumopathie bactérienne</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Community-Acquired Infections</term>
<term>Cross Infection</term>
<term>Pneumonia, Bacterial</term>
<term>Pneumonia, Pneumococcal</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en">
<term>Community-Acquired Infections</term>
<term>Cross Infection</term>
<term>Pneumonia, Bacterial</term>
<term>Pneumonia, Pneumococcal</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Antibactériens</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en">
<term>Community-Acquired Infections</term>
<term>Cross Infection</term>
<term>Pneumonia, Bacterial</term>
<term>Pneumonia, Pneumococcal</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr">
<term>Infection croisée</term>
<term>Infections communautaires</term>
<term>Pneumonie à pneumocoques</term>
<term>Pneumopathie bactérienne</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Infection croisée</term>
<term>Infections communautaires</term>
<term>Pneumonie à pneumocoques</term>
<term>Pneumopathie bactérienne</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antibactériens</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr">
<term>Infection croisée</term>
<term>Infections communautaires</term>
<term>Pneumonie à pneumocoques</term>
<term>Pneumopathie bactérienne</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Comorbidity</term>
<term>Cost of Illness</term>
<term>Hospital Mortality</term>
<term>Humans</term>
<term>Intensive Care Units</term>
<term>Residence Characteristics</term>
<term>Risk Factors</term>
<term>Survival Rate</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Allemagne</term>
<term>Caractéristiques de l'habitat</term>
<term>Comorbidité</term>
<term>Coûts indirects de la maladie</term>
<term>Facteurs de risque</term>
<term>Humains</term>
<term>Mortalité hospitalière</term>
<term>Taux de survie</term>
<term>Unités de soins intensifs</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Mortality of pneumonia is low in the outside setting (1%) but rises up to 20% in hospital admitted patients. Early diagnosis and standardized therapy improve patient's prognosis. For community acquired pneumonia age, comorbidity and the setting of therapy (outside department, normal ward or intensive care unit) are the most important variables to choose an adequate antibiotic treatment. For nosocomial pneumonia risk stratification is according to severity of illness, length of hospital stay and antibiotic pretreatment. In the outpatient setting a 7-day monotherapy is mostly successful. In severe illness the combination of a betalactam antibiotic with a new fluorchinolon seems to be superior to an aminoglycosid therapy. Antibiotic resistance due to mistakes in antibiotic therapy is an increasing problem in the intensive care unit. Therefore, pneumonia preventive measures like influenza and pneumococcal vaccination become more important. Standardized hygienical procedures help to reduce nosocomial, mainly ventilator associated pneumonia.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">14567088</PMID>
<DateCompleted>
<Year>2004</Year>
<Month>02</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>05</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0020-9554</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>44 Suppl 1</Volume>
<PubDate>
<Year>2003</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Der Internist</Title>
<ISOAbbreviation>Internist (Berl)</ISOAbbreviation>
</Journal>
<ArticleTitle>[Community-acquired and nosocomial pneumonia].</ArticleTitle>
<Pagination>
<MedlinePgn>S44-58</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Mortality of pneumonia is low in the outside setting (1%) but rises up to 20% in hospital admitted patients. Early diagnosis and standardized therapy improve patient's prognosis. For community acquired pneumonia age, comorbidity and the setting of therapy (outside department, normal ward or intensive care unit) are the most important variables to choose an adequate antibiotic treatment. For nosocomial pneumonia risk stratification is according to severity of illness, length of hospital stay and antibiotic pretreatment. In the outpatient setting a 7-day monotherapy is mostly successful. In severe illness the combination of a betalactam antibiotic with a new fluorchinolon seems to be superior to an aminoglycosid therapy. Antibiotic resistance due to mistakes in antibiotic therapy is an increasing problem in the intensive care unit. Therefore, pneumonia preventive measures like influenza and pneumococcal vaccination become more important. Standardized hygienical procedures help to reduce nosocomial, mainly ventilator associated pneumonia.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Welte</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Bereich Pneumologie und internistische Intensivmedizin, Otto-von-Guericke-Universität Magdeburg. tobias.welte@medizin.uni-magdeburg.de</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Ambulant erworbene und nosokomiale Pneumonie.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Internist (Berl)</MedlineTA>
<NlmUniqueID>0264620</NlmUniqueID>
<ISSNLinking>0020-9554</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018410" MajorTopicYN="N">Pneumonia, Bacterial</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011018" MajorTopicYN="N">Pneumonia, Pneumococcal</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012111" MajorTopicYN="N">Residence Characteristics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2003</Year>
<Month>10</Month>
<Day>22</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2004</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2003</Year>
<Month>10</Month>
<Day>22</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">14567088</ArticleId>
<ArticleId IdType="doi">10.1007/s00108-003-0964-y</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Semin Respir Infect. 1997 Dec;12(4):278-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9436955</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pneumologie. 2002 Dec;56(12):807-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12486620</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 1999 Aug;12 Suppl 2:S67-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10528788</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2002 Jan 31;346(5):334-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11821511</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2003 Jan 1;36(1):53-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12491202</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 1993 Feb;103(2):547-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8432152</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 1995 Aug 23-30;274(8):639-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7637145</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Respir J. 2001 May;17(5):1034-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11488306</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Respir J. 2003 Feb;21(2):209-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12608431</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 1994 Jul;106(1):221-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8020275</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Intensive Care Med. 1995 Apr;21(4):365-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7650262</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Antimicrob Chemother. 2002 Sep;50 Suppl S1:25-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12239226</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thorax. 1989 Dec;44(12):1031-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2515602</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1997 Jan 23;336(4):243-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8995086</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2002 Dec 15;35(12):1457-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12471563</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pneumologie. 2003 Jan;57(1):27-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12528065</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2002 Apr 15;34(8):1076-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11914996</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Ther. 1998 Jul-Aug;20(4):820-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9737840</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2001 Jun;163(7):1730-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11401897</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 1994 Mar;38(3):547-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8203853</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 1996 May;153(5):1711-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8630626</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Z Med J. 1997 Sep 26;110(1052):349-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9364175</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pneumologie. 2003 Jan;57(1):34-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12528066</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infection. 1997 Jul-Aug;25(4):199-202</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9266256</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):645-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11254518</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diagn Microbiol Infect Dis. 2002 Jan;42(1):21-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11821167</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 1998 Feb;157(2):531-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9476869</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Respir J. 1998 Apr;11(4):986-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9623709</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 1997 Mar;111(3):676-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9118708</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1999 Nov 27;354(9193):1851-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10584721</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Antimicrob Chemother. 2003 Apr;51(4):947-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12654763</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 1998 Apr;26(4):811-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9564457</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Clin Microbiol Infect Dis. 1992 Jun;11(6):504-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1526233</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drugs. 2001;61(4):525-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11324682</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2000 Jul;162(1):119-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10903230</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):505-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10934078</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 1999 Jul;116(1):40-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10424501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Antimicrob Chemother. 1999 Dec;44(6):799-810</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10590282</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 1997 Jun 20;46(24):556-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9221324</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 1996 Jan 10;275(2):134-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8531309</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 1999 Nov 8;159(20):2437-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10665892</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 1997 Aug;112(2):458-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9266884</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pneumologie. 2001 Mar;55(3):135-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11293848</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 1998 Jun;113(6):1542-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9631791</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 1999 Jan;159(1):188-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9872838</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 1999 Jan 25;159(2):182-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9927102</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Antimicrob Chemother. 2002 Jul;50(1):151-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12613473</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Radiology. 1977 Sep;124(3):607-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">887748</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Medicine (Baltimore). 1990 Sep;69(5):307-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2205784</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Burns. 1999 Nov;25(7):640-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10563691</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thorax. 2001 Apr;56(4):296-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11254821</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2000 Feb 9;283(6):749-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10683053</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 1997 Jul 14;157(13):1453-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9224224</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 1998 Dec;158(6):1839-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9847276</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Respir J. 1996 Aug;9(8):1590-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8866577</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pneumologie. 2002 Nov;56(11):695-703</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12442211</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anesthesiology. 1995 Apr;82(4):903-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7717562</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 1995 Feb 1;122(3):179-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7810935</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Intensive Care Med. 2002 Nov;28(11):1521-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12583368</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2000 Oct 14;356(9238):1307-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11073019</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2002 Sep 9;162(16):1849-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12196083</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 1998 Nov;4(11):1241-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9809543</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 2000 Jun;117(6):1638-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10858396</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2002;8 Suppl 3:21-32; discussion 33-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12519346</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2002 Oct 15;166(8):1029-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12379544</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2001;18 Suppl 1:S39-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11574194</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Antimicrob Chemother. 2001 Aug;48(2):209-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11481290</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 1998 Mar;26(3):742-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9524853</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 1963 May 10;140(3567):662</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14020096</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2002 Feb 15;185(4):481-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11865400</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pneumologie. 1999 Oct;53(10):499-510</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10596553</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 1999 Feb;115(2):462-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10027448</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
</list>
<tree>
<country name="Allemagne">
<noRegion>
<name sortKey="Welte, T" sort="Welte, T" uniqKey="Welte T" first="T" last="Welte">T. Welte</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000544 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000544 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeAllemagneV4
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:14567088
   |texte=   [Community-acquired and nosocomial pneumonia].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:14567088" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeAllemagneV4 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Mon Aug 10 17:53:30 2020. Site generation: Sat Mar 27 17:40:37 2021